Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 2 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Dr. Charlotte VAN NOTEN, Nefrologie from Tervuren, company number BE0553608593, closed financial year 2025 with a result of € 271,260 after tax. For that financial year Dr. Charlotte VAN NOTEN, Nefrologie recorded a gross margin of € 468,141 and equity of € 292,778. Compared with financial year 2024, the result moved from € 240,520 to € 271,260. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ 292,778
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 271,260
▲ 13% vs 2024
Profit after tax over the fiscal year.
€ 4,490
▼ 83% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 240,000 paid out
88 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 1,381
▼ 45% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.4 million
▼ 5% vs 2024
€ 76,286 is repaid this year. At this pace the long-term loan is gone in ≈ 18 years.
€ 876
▼ 89% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 63,281
▲ 32% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 321,598 | € 417,169 | € 404,733 | € 468,141 | ▲ 16% |
| Profit after taxes | € 171,301 | € 240,795 | € 240,520 | € 271,260 | ▲ 13% |
| Equity | € 425,203 | € 345,998 | € 261,518 | € 292,778 | ▲ 12% |
| Total debts | € 1,535,047 | € 1,590,916 | € 1,674,167 | € 1,595,897 | ▼ 5% |
| Cash | € 8,453 | € 717 | € 26,031 | € 4,490 | ▼ 83% |
| Land & buildings | € 1,725,556 | € 1,721,005 | € 1,715,556 | € 1,697,377 | ▼ 1% |
| Retained profit | € 406,653 | € 327,448 | € 242,968 | € 274,228 | ▲ 13% |
| Dividend | € 0 | € 320,000 | € 325,000 | € 240,000 | ▼ 26% |
| Bank debt | € 1,302,418 | € 1,222,205 | € 1,447,226 | € 1,374,313 | ▼ 5% |
| Balance sheet total | € 1,960,250 | € 1,936,915 | € 1,935,685 | € 1,888,674 | ▼ 2% |
Key figures of Dr. Charlotte VAN NOTEN, Nefrologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Charlotte VAN NOTEN, Nefrologie?
What happened at Dr. Charlotte VAN NOTEN, Nefrologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 271,260 (▲ 13% vs 2024). Source: NBB ↗
- New establishment in Tervuren. KBO
- Start of the company according to the CBE. KBO
In short
From € 171,301 profit in 2022 to € 271,260 profit in 2025.
Paid € 300,049 in corporate taxes since 2022.
Best year ever: 2025, with € 271,260 profit.
Paid out € 885,000 in dividends to the owners in total.
A new publication or filing at Dr. Charlotte VAN NOTEN, Nefrologie? We notify you, reason included.
Follow Dr. Charlotte VAN NOTEN, NefrologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. Charlotte VAN NOTEN, Nefrologie is Charlotte Brigitte Van Noten.
Directors
According to the 2025 annual accounts
Charlotte Brigitte Van Noten
Director
Establishments
Establishment units
Physical locations of this company
Eikestraat 96
3080 Tervuren
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0553.608.593
- VAT number
- BE 0553.608.593
- Registered office
- Eikestraat 96, 3080 Tervuren
- Names & denominations
- Dr. Charlotte VAN NOTEN, Nefrologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 June 2014
- Peppol
- Active · Active since 29 Jun 2026